GAMMA Investing’s Ultralife ULBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$897 Hold
142
﹤0.01% 3902
2026
Q1
$926 Hold
142
﹤0.01% 3854
2025
Q4
$812 Sell
142
-80
-36% -$494 ﹤0.01% 3843
2025
Q3
$1.51K Sell
222
-63
-22% -$477 ﹤0.01% 3519
2025
Q2
$2.56K Buy
285
+144
+102% +$854 ﹤0.01% 3333
2025
Q1
$759 Buy
141
+116
+464% +$788 ﹤0.01% 3611
2024
Q4
$186 Buy
+25
New +$206 ﹤0.01% 3712
2024
Q2
Sell
-61
Closed -$537 3514
2024
Q1
$537 Hold
61
﹤0.01% 3093
2023
Q4
$431 Buy
+61
New +$501 ﹤0.01% 2994

Other funds holding ULBI

GAMMA Investing's ULBI Position: Q2 2026 in Review

GAMMA Investing held its Ultralife (ULBI) position steady in Q2 2026 at 142 shares worth $897. The position accounts for ﹤0.01% of the portfolio, ranked #3902.

GAMMA Investing first reported a position in ULBI in Q4 2023 and has held it in 9 quarters since. The position peaked at $2.56K in Q2 2025. 2 funds tracked by Wall St. Rank hold ULBI as of Q2 2026.

  • GAMMA Investing held 142 shares of Ultralife worth $897 as of Q2 2026.
  • GAMMA Investing left its Ultralife share count unchanged in Q2 2026.
  • Ultralife made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3902 holding.
  • GAMMA Investing first reported a position in Ultralife in Q4 2023 and has held it in 9 quarters since.
  • GAMMA Investing's Ultralife position peaked at $2.56K in Q2 2025.
  • 2 funds tracked by Wall St. Rank held Ultralife as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.